91 related articles for article (PubMed ID: 12359135)
1. Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.
Mistry PK; Sirrs S; Chan A; Pritzker MR; Duffy TP; Grace ME; Meeker DP; Goldman ME
Mol Genet Metab; 2002; 77(1-2):91-8. PubMed ID: 12359135
[TBL] [Abstract][Full Text] [Related]
2. Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD).
Shaw JG; Dent AG; Passmore LH; Burstow DJ; Bowman RV; Zimmerman PV; Fong KM; Yang IA
BMC Pulm Med; 2012 Jun; 12():25. PubMed ID: 22695028
[TBL] [Abstract][Full Text] [Related]
3. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.
Taddei TH; Kacena KA; Yang M; Yang R; Malhotra A; Boxer M; Aleck KA; Rennert G; Pastores GM; Mistry PK
Am J Hematol; 2009 Apr; 84(4):208-14. PubMed ID: 19260119
[TBL] [Abstract][Full Text] [Related]
4. Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease.
Andrade-Campos MM; de Frutos LL; Cebolla JJ; Serrano-Gonzalo I; Medrano-Engay B; Roca-Espiau M; Gomez-Barrera B; Pérez-Heredia J; Iniguez D; Giraldo P
Orphanet J Rare Dis; 2020 Sep; 15(1):256. PubMed ID: 32962737
[TBL] [Abstract][Full Text] [Related]
5. [Genetic characteristics and clinical analysis of 20 patients with Gaucher's disease].
Zhang TB; Wen XL; Zhang XL; Yan JR; Hao GP; Yang LH; Zhang RJ
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):82-85. PubMed ID: 38527843
[TBL] [Abstract][Full Text] [Related]
6. Role of Partial Splenectomy in Gaucher's Disease in Resource Challenged Nations.
Santanakrishnan R; Dasaratha V; Munianjanappa NB; Javaregowda D; Saroja MG
J Indian Assoc Pediatr Surg; 2023; 28(2):149-153. PubMed ID: 37197236
[TBL] [Abstract][Full Text] [Related]
7. Nine-year experience in Gaucher disease diagnosis at the Spanish reference center Fundación Jiménez Díaz.
Ortiz-Cabrera NV; Gallego-Merlo J; Vélez-Monsalve C; de Nicolas R; Mas SF; Ayuso C; Trujillo-Tiebas MJ
Mol Genet Metab Rep; 2016 Dec; 9():79-85. PubMed ID: 27872820
[TBL] [Abstract][Full Text] [Related]
8. A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach.
Feng S; Rcheulishvili N; Jiang X; Zhu P; Pan X; Wei M; Wang PG; Ji Y; Papukashvili D
Int J Biol Sci; 2024; 20(6):2111-2129. PubMed ID: 38617529
[TBL] [Abstract][Full Text] [Related]
9. The role of cardiac imaging in assessing the cardiac involvement of type 1 Gaucher disease: a case report with review of literature.
Addou AY; El Mire W; Doghmi N; Benyass A
Egypt Heart J; 2024 Mar; 76(1):35. PubMed ID: 38523185
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Pulmonary and Respiratory Conditions in Gaucher Disease from 2000 to 2020: A Multi-institutional Cohort Study.
Huang YN; Huang JY; Liao WL; Chiang SL; Liu KW; Bau DT; Wang CH; Su PH
In Vivo; 2023; 37(5):2276-2283. PubMed ID: 37652520
[TBL] [Abstract][Full Text] [Related]
11. Two Case Reports of Progressive Pulmonary Hypertension with Type-1 Gaucher Disease: Efficient PAH-Specific Therapy and 1-Year Follow-Up.
Yağmur B; Nalbantgil S; Kayıkçıoğlu M
Anatol J Cardiol; 2022 Jul; 26(7):584-588. PubMed ID: 35791716
[No Abstract] [Full Text] [Related]
12. Rare Diseases in Glycosphingolipid Metabolism.
Zhou H; Wu Z; Wang Y; Wu Q; Hu M; Ma S; Zhou M; Sun Y; Yu B; Ye J; Jiang W; Fu Z; Gong Y
Adv Exp Med Biol; 2022; 1372():189-213. PubMed ID: 35503182
[TBL] [Abstract][Full Text] [Related]
13. In-depth phenotyping for clinical stratification of Gaucher disease.
D'Amore S; Page K; Donald A; Taiyari K; Tom B; Deegan P; Tan CY; Poole K; Jones SA; Mehta A; Hughes D; Sharma R; Lachmann RH; Chakrapani A; Geberhiwot T; Santra S; Banka S; Cox TM;
Orphanet J Rare Dis; 2021 Oct; 16(1):431. PubMed ID: 34649574
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Manifestations in a Group of Romanian Patients with Gaucher Disease Type 1 (a Monocentric Study).
Lazea C; Bucerzan S; Al-Khzouz C; Zimmermann A; Vesa ȘC; Nașcu I; Creț V; Crișan M; Asăvoaie C; Miclea D; Grigorescu-Sido P
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34072542
[TBL] [Abstract][Full Text] [Related]
15. Interstitial lung disease in lysosomal storage disorders.
Borie R; Crestani B; Guyard A; Lidove O
Eur Respir Rev; 2021 Jun; 30(160):. PubMed ID: 33927007
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.
Al-Qadi M; LeVarge B; Ford HJ
Front Med (Lausanne); 2020; 7():616720. PubMed ID: 33842491
[TBL] [Abstract][Full Text] [Related]
17. Gaucher disease: Basic and translational science needs for more complete therapy and management.
Grabowski GA; Antommaria AHM; Kolodny EH; Mistry PK
Mol Genet Metab; 2021 Feb; 132(2):59-75. PubMed ID: 33419694
[No Abstract] [Full Text] [Related]
18. The future is here: Integrating genetics into the pediatric pulmonary clinic.
Hawley MH; Moschovis PP; Lu M; Kinane TB; Yonker LM
Pediatr Pulmonol; 2020 Jul; 55(7):1810-1818. PubMed ID: 32533912
[TBL] [Abstract][Full Text] [Related]
19. Recognizing genetic disease: A key aspect of pediatric pulmonary care.
Yonker LM; Hawley MH; Moschovis PP; Lu M; Kinane TB
Pediatr Pulmonol; 2020 Jul; 55(7):1794-1809. PubMed ID: 32533909
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
